Mirum Pharmaceuticals Inc
MIRM - Insider Information
Get informed when a big investor buys or sells
+ FollowMarket Cap$6.15B
Close$
$27.50
71.6% downside
Current Fair Value
71.6% downsideOvervalued by 71.6% based on the discounted cash flow analysis.
Insider Trades
Loading insider trades…
Congress Trades
Loading congress trades…
Share Statistics
| Market cap | $6.15 Billion |
|---|---|
| Enterprise Value | $6.58 Billion |
| Earnings per Share | $-0.47 |
| Beta | 0.49 |
| Outstanding Shares | 63,374,183 |
Return
| Return on Equity | 8253.76% |
|---|---|
| Return on Assets | -82.32% |
| Return on Invested Capital | -98.09% |
Valuation & Multiples
| P/E Ratio | -5.84 |
|---|---|
| PEG | -0.56 |
| Price to Sales | 13.85 |
| Price to Book Ratio | -96.97 |
| Enterprise Value to Revenue | 14.35 |
| Enterprise Value to EBIT | -8.15 |
| Enterprise Value to Net Income | -8 |
| Total Debt to Enterprise | 0.12 |
| Debt to Equity | -72.97 |
Revenue Sources
No data
Last Earnings Call
Report Date
November 3, 2026
EPS Estimate
$-0.49
Consensus analyst estimateRevenue Estimate
$178.08 M
Consensus analyst estimateNext Earnings Call
Expected Date
February 24, 2027
EPS Estimate
$-0.58
Consensus analyst estimateRevenue Estimate
$194.47 M
Consensus analyst estimateInstitutional Put/Call Ratio
Compares institutional put options with call options. At 0.00, the ratio is below 1, so institutions hold more calls than puts.
| Put/Call Ratio | 0.0000▼ 48.55% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 0.62%▼ 121.52% |
|---|---|
| Total Invested | $33.05M▼ 99.61% |
| Investors Holding | 61▼ 277.00% |